October 24, 2020

The Psychopharmacology Update Virtual platform will close on 12/24/20 at midnight

CLICK HERE for more Psychiatry CME


Register Now

Agenda

LIVE BONUS PRESENTATIONS OCTOBER 21 & 22, 2020
OPTIONAL CONFERENCE WORKSHOP: OCTOBER 23, 2020
LIVE GENERAL SESSIONS OCTOBER 24, 2020

 

Friday, October 23, 2020

(Eastern Time)

OPTIONAL WORKSHOPS

FEATURING LIVE Q&A
Addiction Workshop

Director: Edwin Salsitz, MD

10:00 AM - 12:00 PM
  • The Neurobiology of Addiction: Understanding Addiction from the Inside Out
  • Treatment of Substance Use Disorders
  • Interesting Case Presentations

12:00 AM - 12:30 PM

LIVE Interactive Q&A

12:30 PM – 12:40 PM

BREAK

 

Cannabis Workshop

Director: Diana Martinez, MD

12:40 PM - 1:50 PM
  • Medicinal Cannabis: The Science and the Promise of THC and CBD
  • The Impact of Cannabis Use on Psychiatric Disorders

1:50 PM - 2:20 PM

LIVE Interactive Q&A

2:20 PM – 2:30 PM

BREAK

 

Telepsychiatry Workshop

Director: Sanjay Gupta, MD
Faculty: Bradford L. Frank, MD, MPH, MBA

2:30 PM – 3:30 PM
  • Telepsychiatry during the COVID Pandemic
  • “Hands-on” demonstration
  • Legal, Licensure and Ethical Issues

3:30 PM - 4:00 PM

LIVE Interactive Q&A
 

Saturday, October 24, 2020

(Eastern Time)

DRUG SELECTION IN PSYCHOPHARMACOLOGY: AN EVIDENCE-BASED APPROACH

8:15 AM - 8:17 AM

Welcome and Course Overview
Henry A. Nasrallah, MD

8:17 AM - 9:02 AM

BIPOLAR DISORDER
Joseph F. Goldberg, MD

Drug Selection For:
a) No Psychosis
b) With Psychosis
c) With Anxiety
d) With ADHD
e) With Metabolic Syndrome

9:02 AM - 9:47 AM

MAJOR DEPRESSION
Joseph F. Goldberg, MD

Drug Selection Based On:
a) Age
b) Gender
c) Comorbid Anxiety
d) Psychotic Features
e) Treatment Resistance
f) Treatment Refractory

9:47 AM – 10:02 AM

Q&A Panel with Faculty

10:02 AM – 10:15 AM

BREAK

10:15 AM - 11:00 AM

PSYCHOSIS
Henry A. Nasrallah, MD

Drug Selection For:
a) First Episode
b) Subchronic Phase
c) Treatment Resistant
d) With Medical Comorbidities
e) Suicidal/Homicidal Ideas

11:00 AM – 11:45 AM

ANXIETY
Jeffrey R. Strawn, MD

Drug Selection For:
a) AD
b) Social Anxiety
c) Panic Disorder
d) Depressive Features

11:45 AM – 12:30 PM

ADHD
Jeffrey R. Strawn, MD

Drug Selection For:
a) Children
b) Adolescents
c) Adults
d) Comorbid Bipolar

12:30 PM  – 1:15 PM

OCD
Wayne K. Goodman, MD

Drug Selection For:
a) Obsessions and Compulsions
b) With Comorbid Tics
c) With Comorbid Depression
d) With Comorbid Psychosis
e) Neuromodulation

1:15 PM  – 2:00 PM

SLEEP DISORDERS
Ruth Benca, MD

Drug Selection For:
a) Primary Insomnia
b) Insomnia Secondary to a Psychiatric Illness
c) Hypersomnia, Narcolepsy

2:00 PM  – 2:30 PM

Q&A Panel with Faculty

2:30 PM

Adjournment

 

  

 

Follow Us

Jointly Provided By